Comparative Effectiveness of Sitagliptin Compared to Sulphonylureas for Type 2 Diabetes Among Elderly Patients Inadequately Controlled on Metformin

被引：0
|
作者：
Sharma, Manuj [1 ]
Nazareth, Irwin [1 ]
Petersen, Irene [1 ,2 ]
机构：
[1] UCL, London, England
[2] Aarhus Univ Hosp, Aarhus, Denmark
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2017年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
730
引用
收藏
页码：440 / 440
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of acarbose in patients with type 2 diabetes inadequately controlled with metformin
    Magner, J
    Taylor, T
    Krol, A
    Rosenstock, J
    DIABETOLOGIA, 1998, 41 : A231 - A231
  • [22] Efficacy and safety of acarbose in patients with type 2 diabetes inadequately controlled with metformin
    Rosenstock, J
    Magner, J
    Krol, A
    Taylor, T
    DIABETES, 1998, 47 : A351 - A351
  • [23] Cardiovascular safety of metformin and sulphonylureas in type 2 diabetes patients
    Ioacara, S.
    Roden, M.
    Guja, C.
    Ionescu-Tirgoviste, C.
    Reghina, A.
    Georgescu, O.
    Fica, S.
    DIABETOLOGIA, 2014, 57 : S318 - S318
  • [24] Exenatide elicits sustained glycaemic control and progressive reduction of body weight in patients with type 2 diabetes inadequately controlled by sulphonylureas with or without metformin
    Riddle, Matthew C.
    Henry, Robert R.
    Poon, Terri H.
    Zhang, Bei
    Mac, Susanna M.
    Holcombe, John H.
    Kim, Dennis D.
    Maggs, David G.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2006, 22 (06) : 483 - 491
  • [25] EFFECTS OF COLESEVELAM, ROSIGLITAZONE, OR SITAGLIPTIN ON GLYCEMIC CONTROL AND LIPID PROFILE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED BY METFORMIN MONOTHERAPY
    Rigby, Scott. P.
    Handelsman, Yehuda
    Lai, Yu-Ling
    Abby, Stacey L.
    Tao, Ben
    Jones, Michael R.
    ENDOCRINE PRACTICE, 2010, 16 (01) : 53 - 63
  • [26] Ertugliflozin Compared with Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: The VERTIS SU Randomized Study
    Hollander, Priscilla
    Liu, Jie
    Hill, Julie
    Johnson, Jeremy
    Jiang, Zhi Wei
    Golm, Gregory
    Huyck, Susan
    Terra, Steven G.
    Mancuso, James P.
    Engel, Samuel S.
    Lauring, Brett
    DIABETES THERAPY, 2018, 9 (01) : 193 - 207
  • [27] Safety and efficacy of ertugliflozin compared to glimepiride in patients with type 2 diabetes inadequately controlled on metformin: the VERTIS SU trial
    Hollander, P.
    Liu, J.
    Hill, J.
    Johnson, J.
    Jiang, Z.
    Golm, G.
    Huyck, S.
    Terra, S.
    Mancuso, J. P.
    Engel, S.
    Lauring, B.
    DIABETOLOGIA, 2017, 60 : S19 - S20
  • [28] Ertugliflozin Compared with Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: The VERTIS SU Randomized Study
    Priscilla Hollander
    Jie Liu
    Julie Hill
    Jeremy Johnson
    Zhi Wei Jiang
    Gregory Golm
    Susan Huyck
    Steven G. Terra
    James P. Mancuso
    Samuel S. Engel
    Brett Lauring
    Diabetes Therapy, 2018, 9 : 193 - 207
  • [29] Efficacy and safety of ipragliflozin as an add-on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial
    Han, Kyung-Ah
    Chon, Suk
    Chung, Choon Hee
    Lim, Soo
    Lee, Kwan-Woo
    Baik, SeiHyun
    Jung, Chang Hee
    Kim, Dong-Sun
    Park, Kyong Soo
    Yoon, Kun-Ho
    Lee, In-Kyu
    Cha, Bong-Soo
    Sakatani, Taishi
    Park, Sumi
    Lee, Moon-Kyu
    DIABETES OBESITY & METABOLISM, 2018, 20 (10): : 2408 - 2415
  • [30] Clinical outcomes and health care costs combining metformin with sitagliptin or sulphonylureas or thiazolidinediones in uncontrolled type 2 diabetes patients
    Degli Esposti, Luca
    Saragoni, Stefania
    Buda, Stefano
    Degli Esposti, Ezio
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2014, 6 : 463 - 472
12345